International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s): 321

Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V Allen, Jr., PhD, RPh, formulation, midazolam, benzodiazepine, preoperative sedation, sleep, procedural sedation, anxiolysis, anesthesia, anterograde amnesia

Related Categories: FORMULATIONS, MENTAL HEALTH, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Allen Loyd V Jr	Jul/Aug 2018 Pg. 321
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Geiger Christine M, Sorenson Bridget, Whaley Paul A	Jul/Aug 2013 Pg. 344-346
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Midazolam 5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 162
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Lorazepam 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 143
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Allen Loyd V Jr	Mar/Apr 2022 Pg. 146
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Voudrie Mark A II, Allen D Brett	Jan/Feb 2010 Pg. 82-85
Midazolam Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 387
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 493
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jan/Feb 2020 Pg. 54
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul	Sep/Oct 2015 Pg. 420-427
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Allen Loyd V Jr	Jul/Aug 2020 Pg. 319
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei	Jan/Feb 2011 Pg. 74-77
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 492
Return to Top